KRM22 Achieves Maiden Adjusted EBITDA Profit Amid 22% ARR Growth in 2024

KRM22 Hits Profitability Milestone: Why This Matters for Investors

Let’s raise a cuppa to milestones, shall we? KRM22 just delivered its first-ever adjusted EBITDA profit – a £1m swing from last year’s £1.4m loss. For a company that’s been playing the long game in capital markets risk tech, this isn’t just progress – it’s proof the strategy’s gaining serious traction.

The Numbers That Made 2024 Sparkle

• ARR rocket fuel: 22% annual growth to £6.6m (already £7.4m post-year-end)
• Revenue surge: 28% increase to £6.8m, with 92% from recurring contracts
• Cost discipline: £1.2m annual savings from restructuring – leaner but not meaner

Behind the Scenes: How They Pulled It Off

New CEO Dan Carter didn’t just rearrange the deckchairs. The 2024 playbook had three winning moves:

1. Product Innovation That Sticks

Their new Risk Manager application contributed 48% of new ARR – like launching a hit single that immediately tops the charts. Meanwhile, Limits Manager and Market Surveillance kept existing clients spending more (31% and 19% of new ARR respectively).

2. Strategic Partnerships With Teeth

The Trading Technologies (TT) relationship isn’t just a press release fling – it’s delivering £0.9m ARR and crucial deferred loan terms. This isn’t dating; it’s a full-blown financial marriage with shared tech integration.

3. Surgical Cost Management

That £1.2m savings didn’t come from skipping biscuits in the breakroom. Streamlined ops and focused R&D (still £1.1m capitalised) show maturity – spending smart, not just spending less.

The Elephant in the Boardroom: That TT Convertible Loan

Let’s not gloss over the £5.3m debt overhang. The recent amendments (deferring interest until 2026) buy breathing room, but covenant risks remain. My take? This looks manageable if ARR growth stays above 20%. The key dates to watch:

• December 2025 cash covenant test
• June 2026 loan maturity

Why Capital Markets Are Biting

As Garry Jones notes, volatility is the new normal. With regulators dishing out fines like parking tickets, KRM22’s sweet spot – real-time risk analytics – couldn’t be timelier. Their push into equities/FX/crypto (beyond core derivatives) could triple their £6bn SaaS market slice.

2025 Outlook: Runway Lights Are Green

With £7.4m ARR already banked and:

• TT partnership scaling up surveillance sales
• AI enhancements rolling out in Market Surveillance
• Multi-asset expansion underway

This could be the inflection point growth investors crave. But keep your eyes on two metrics: gross retention (currently 92%) and TT-related ARR concentration (currently 14%).

Final Thought: More Than Just a Profit

KRM22’s not just selling software – they’re selling financial stability in unstable times. That first EBITDA profit isn’t a finish line; it’s proof their product-market fit works. As risk management shifts from compliance checkbox to competitive advantage, this AIM player might just become a mainstage act.